CGRPvasta

CGRPvasta is a medication used to treat chronic migraine. It is a calcitonin gene-related peptide (CGRP) receptor antagonist, which means it works by blocking the action of CGRP, a protein that plays a role in the development of migraine headaches. CGRPvasta is administered via subcutaneous injection, typically once a month. It is available in a pre-filled syringe for ease of use. The medication is indicated for adults who have at least 4 migraine days per month, with at least 1 of those days being a migraine with aura. CGRPvasta is not recommended for patients who have a history of ischemic stroke or transient ischemic attack, or those who are allergic to any of its components. Common side effects may include injection site reactions, flu-like symptoms, and fatigue. Serious side effects are rare but can include serious allergic reactions and neurological events. CGRPvasta should be used with caution in patients with certain medical conditions, such as liver or kidney disease, and in those who are pregnant or breastfeeding. It is important to follow the prescribed dosage and administration schedule, and to consult with a healthcare provider for any concerns or questions regarding its use.